Catalog Advanced Search
-
Contains 3 Component(s)
Tune to the APSHO Radiation Oncology APP Network for a webinar on Theranostics - Cancer Treatment with Precision Medicine by Jamie Raney, MBA, CNMT
Tune to the APSHO Radiation Oncology APP Network for a webinar on Theranostics - Cancer Treatment with Precision Medicine by Jamie Raney, MBA, CNMT
- What is Theranostics? A high-level overview of Theranostics
- Programs of Excellence: What good looks like
- The Theranostics of Tomorrow: Innovations shaping the future
- Impact of Theranostics in Radiation Therapy
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
1. What is Theranostics? A High-Level Overview
- Define the concept of theranostics and explain its role in cancer treatment.
- Identify the key components and principles behind theranostic approaches.
- Describe the clinical applications and benefits of theranostics in cancer care.
2. Programs of Excellence: What Good Looks Like
- Analyze the characteristics of successful theranostic programs.
- Evaluate best practices for implementing theranostics in clinical settings.
3. The Theranostics of Tomorrow: Innovations Shaping the Future
- Explore emerging technologies and innovations driving theranostics forward.
- Predict potential future applications and trends in theranostic research.
- Assess the impact of AI, imaging, and molecular targeting on theranostics.
4. Impact of Theranostics in Radiation Therapy
- Explain how theranostics integrates with radiation therapy workflows.
- Assess the clinical outcomes and patient benefits of theranostic-guided radiation therapy.
- Discuss challenges and opportunities in combining theranostics with radiotherapy.
Jamie Raney, MBA, CNMT
Care Pathway Leader for Theranostics Strategy and Growth
GE Healthcare
Jamie Raney is a seasoned healthcare executive with over two decades of experience in nuclear medicine, theranostics, and imaging operations. Currently serving as the Care Pathway Leader for Theranostics Strategy and Growth at GE HealthCare, Jamie partners with providers across the U.S. and Canada to enable and optimize cutting-edge theranostics programs that elevate patient care and operational efficiency.
Jamie's career spans leadership roles in both clinical and corporate settings, including as Regional Director of Operations at CDL Nuclear Technologies, Director of Imaging and Nuclear Medicine for Rocky Mountain Cancer Centers, and as Practice Administrator at BAMF Health, where he launched the clinical operations of a state-of-the-art Theranostics Center. His expertise also includes consulting for a national radiopharmacy network and serving as a Medical Science Liaison for Telix Pharmaceuticals, where he provided support in the pre-launch of illuccix as well as the research pipeline.
With a strong foundation in nuclear medicine technology and a Master of Business Administration in Healthcare Management, Jamie brings a unique blend of clinical insight and strategic acumen. He is a Certified Nuclear Medicine Technologist and an active member of the Society of Nuclear Medicine and Molecular Imaging.
Jamie is passionate about advancing theranostics and molecular imaging to improve outcomes for patients and communities. His leadership is marked by a commitment to operational excellence, innovation, and collaborative growth.
Disclosure: Jamie Raney is the Theranostics Strategy & Growth Care Pathway Leader for the GE HealthCare overseeing United States and Canada.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 3 Product(s)
This multi-session program provides advanced practitioners with a 360-degree view of BTCE therapy, spanning mechanisms of action, clinical trial evidence, patient selection, adverse event recognition and management, and practice implementation. The series blends evidence-based learning with case studies and multidisciplinary perspectives to prepare participants for leadership in BTCE adoption across diverse practice settings. Upon completion, learners will be able to safely and effectively apply BTCEs, improve patient and caregiver education, and contribute to system-level readiness for these novel therapies. Overall Program Learning Objectives: After completing this activity, learners will be able to: · Explain the mechanisms of action and approved indications of BTCEs. · Evaluate clinical data and guidelines supporting BTCE use. · Develop individualized patient treatment plans using BTCEs. · Recognize and manage common BTCE-related toxicities. · Integrate safety protocols into outpatient workflows. · Lead institutional and multidisciplinary efforts for BTCE adoption.
Modules:
Module 1: Clinical Application of Bispecific T-Cell Engagers
Module 2: Bispecific T-Cell Engager Related Adverse Events
Module 3: Implementing Bispecific T-Cell Engagers Into Practice: Mode
© APSHO 2025. All Rights Reserved. The content, materials, and intellectual property presented on this course, including but not limited to text, graphics, images, designs, logos, videos, and code, are the exclusive property of APSHO, unless otherwise noted. Unauthorized reproduction, distribution, or use of any content without prior written permission is strictly prohibited. For inquiries about licensing or permissions, please contact APSHO directly at info@apsho.org.
-
Register
- Non-member - $95
- Member - Free!
- More Information
-
Register
-
Contains 6 Component(s), Includes Credits
This course empowers Advanced Practitioners to confidently conduct peer reviews of abstracts, posters, and manuscripts by applying IMRAD criteria, identifying bias, and structuring feedback effectively. Through case studies and practical tools, participants build skills in evaluating scientific quality, transparency, and methodological rigor. Ideal for APs involved in academic publishing, presentations, or mentoring.
This comprehensive course equips APs with practical skills to confidently review abstracts, posters, and manuscripts
- Pre-test
- Introduction to peer reviewing
- Abstracts
- Posters
- Manuscripts
- Summary
- Post-test
After the completion of this activity, the participant will be able to:
- Identify the key components of written scholarly work, including abstracts, posters, and manuscripts
- Describe sequence of steps required to evaluate scholarly work and provide a valuable peer review
- Implement best practices in providing constructive feedback to submitting authors
Antonia , MSN, ANP-C, ACHPN
Atrium Health Levine Cancer Institute
Antonia Corrigan is the Chief APP for the Department of Supportive Oncology at the Levine Cancer Institute in Charlotte, North Carolina. Throughout her 21-year career, her focus has been oncology and palliative medicine. She has presented nationally and regionally and has designed and participated in multiple institution- based educational activities focusing on the varied aspects of symptom management in the oncology setting.
Antonia Corrigan has no relevant financial relationships to disclose.
-
Register
- Non-member - $25
- Member - Free!
- More Information
-
Contains 16 Product(s)
The Advanced Practitioner Onboarding Course is a 20-hour program designed to prepare Advanced Practitioners (APs) for delivering high-quality, evidence-based oncology care. It covers the full cancer care continuum—from foundational science and diagnostics to treatment, survivorship, and end-of-life care. The course also emphasizes professional development, including clinical research, documentation, and personal well-being. By the end, participants will be equipped to apply evidence-based guidelines, create individualized care plans, contribute to research, and sustain resilience in oncology practice.
The following topics will be covered in this course:
- Introduction to Oncology
- Oncogenesis
- Cancer Screenings, Diagnostics, and Staging
- Lab Testing Breakdown
- Patient Evaluation and Simulation
- Treatment Modalities
- Management of Common Acute Conditions
- Psychosocial and Supportive Care
- Adolescents and Young Adults (AYA) with Cancer
- Health Maintenance and Survivorship
- Palliative Care and Hospice
- The AP’s Role in Research
- Clinical Documentation and EMR Best Practices
- AP Practice Fundamentals and Professional Development
- Physical and Mental Health of the AP
© APSHO 2025. All Rights Reserved. The content, materials, and intellectual property presented on this course, including but not limited to text, graphics, images, designs, logos, videos, and code, are the exclusive property of APSHO, unless otherwise noted. Unauthorized reproduction, distribution, or use of any content without prior written permission is strictly prohibited. For inquiries about licensing or permissions, please contact APSHO directly at info@apsho.org.
-
Register
- Non-member - $300
- Member - $200
- More Information
-
Contains 8 Component(s)
This introductory course offers advanced practitioners a foundational understanding of genomics in oncology. Participants will explore how genetic alterations contribute to cancer development, learn about key biomarker testing methods, and understand the role of genomic profiling in guiding targeted therapy and monitoring treatment resistance
This introductory course offers advanced practitioners a foundational understanding of genomics in oncology. Participants will explore how genetic alterations contribute to cancer development, learn about key biomarker testing methods, and understand the role of genomic profiling in guiding targeted therapy and monitoring treatment resistance.
Outline:
•Introduction
•Cancer: a disease of the genome
•Biomarker testing
•Next generation sequencing (NGS)
•Clinical application
Candice Graham-Adderton DNP, MPH, FNP-C, CHES
Guardant Health
Candice is a family nurse practitioner with over a decade of experience in health care. At Guardant Health, she leverages her clinical and public health expertise to support the use of genomic testing in cancer care. She also co-leads the Guardant Health Advanced Practitioner Education Committee, helping to strengthen education and engagement among oncology advanced practitioners.
Cristin O’Neal MSN, ANP-C
Guardant Health
Cristin O'Neal MSN, ANP-c is an advanced practitioner with 18 years of oncology experience, including 7 years as a nurse practitioner in oncology. She is currently part of the Medical Affairs team at Guardant Health, where she provides molecular education to oncology practices nationwide. Cristin also co-leads the Guardant Health Advanced Practitioner (AP) Education Committee, which supports external training and development for APs in oncology.
Disclaimer: The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Register
-
Contains 3 Component(s)
Tune to the APSHO Radiation Oncology APP Network for a webinar on Radiation for Benign Conditions by Patricia Crabtrey, MSN, APRN, FNP-C, AOCNP.
Tune to the APSHO Radiation Oncology APP Network for a webinar on Radiation for Benign Conditions by Patricia Crabtrey, MSN, APRN, FNP-C, AOCNP
- The expanding role of radiation therapy (RT) in the management of benign conditions.
- RT application in fibroproliferative, degenerative, and functional disorders
- Discussion of RT mechanisms of action, clinical evidence, patient selection, outcomes, and safety considerations for using RT for benign conditions
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
•Understand how and when to use RT for benign conditions and the benefits of early intervention in fibroproliferative diseases through real-world outcomes for pain relief and disease control
•Share with colleagues why RT is gaining traction in multimodal osteoarthritis management
•Utilize safety profiles and long-term outlook for patients
Patricia Crabtrey, MSN, APRN, FNP-C, AOCNP
MD Anderson
Patricia Crabtrey began her nursing career as a Registered Nurse in 1991, she brings a diverse clinical background that includes experience in Emergency Room (ER), Intensive Care Unit (ICU), and Interventional Radiology. Her commitment to patient care and clinical excellence led her to join MD Anderson Cancer Center in 2008, where she began working in the Radiation Oncology department.Initially serving as an RN at one of MD Anderson’s Houston Area Locations, she departed in 2012 to pursue advanced education. In 2013, she earned her Master’s degree from the University of Texas Health Science Center in Houston and returned to MD Anderson in 2014, joining the Genitourinary Radiation Oncology Service.In late 2023, she transitioned to MD Anderson’s Sugar Land location to collaborate with Dr. Shalin Shah, supporting the development and growth of the Benign Program.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 3 Component(s)
Learn how advanced practitioners (APs) can integrate clinical research into their daily practice and explore the various roles they can take on, such as principal or co-investigator. You'll also gain practical tips and resources to help you get started in research within community and academic settings.
Tune to the APSHO Research and Quality Improvement Forum for a webinar on Promoting AP involvement in Clinical Research: Highlighting Pathways in Community and Academic Settings with an expert panel of research advanced practitioners from a diverse group of organizations.
- Career Background: Journey of an oncology APP in clinical research.
- Daily Schedule: Integrating research into a typical workday.
- Tips and Resources: Practical tips for APPs to get involved in research.
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
Christa Braun-Inglis (Moderator)
DNP, APRN-Rx, FNP-BC, AOCNP
University of Hawaii Cancer Center
Christa Braun-Inglis was the first oncology nurse practitioner in the state of Hawaii. Dr. Braun-Inglis has been instrumental on the local and national level in expanding the role of advanced practice providers (APPs) in clinical trials. She has also advocated for cancer clinical trials in the community setting and diverse patient enrollment in clinical trials. With over 25 years of oncology nursing experience, she holds a dual role as both a nurse practitioner and an assistant researcher at the University of Hawaii Cancer Center in Honolulu, Hawaii. She is also a clinical faculty member at the University of Hawaii School of Nursing. Through her efforts, the National Cancer Institute (NCI) revised their policies in 2021, empowering APPs to fully exercise their credentials and enroll patients in supportive care trials. In 2023, she received the National Cancer Institute’s Director’s Award. In addition, she is also the current Chair of the Research and Quality Improvement committee of APSHO.
Christa Braun-Inglis has no relevant financial relationships to disclose.
Lisa A. Kottschade
APRN, MSN, CNP, FAPO, APSHO President
Mayo Clinic
Ms. Lisa A. Kottschade is an Associate Professor of Oncology and a Nurse Practitioner in the Melanoma and Cutaneous Oncology and Immunotherapy Toxicity Clinics at Mayo Clinic. Recently she was named the Chair of Research Committee for the Office of NP/PA in Rochester. She is the current President of APSHO as well as leads the Alliance Oncology Nursing Committee. Her clinical and research interests include those in the field of melanoma including its treatment and management of side effects from therapy with a special focus on those related to Immune Checkpoint Inhibitors.
Lisa A. Kottschade has no relevant financial relationships to disclose.
Mee-young Lee
MSN, ANP-BC, AOCNP
Dana-Farber Cancer Institute
Mee-young Lee is a nurse practitioner with over 25 years of oncology experience. She earned her MSN from the University of Pennsylvania in 2006 and has held clinical roles at Beth Israel Deaconess Medical Center, Northwell Health, and St. Francis Heart Hospital. She currently practices at Dana-Farber Cancer Institute, specializing in thoracic oncology. Mee-young is also an active member of the Research and Quality Improvement Committee of the Advanced Practitioner Society for Hematology and Oncology (APSHO).
Mee-young Lee has no relevant financial relationships to disclose.
Ashley Springer
MSN, AGPCNP-BC, APRN-Rx
Hawaii Cancer Care
Ashley received a Master of Science in nursing degree from University of Hawaii at Manoa. She has been a nurse practitioner in medical oncology and hematology for over 10 years. Ashley is a member of APSHO’s Research and Quality Initiative Task Force. She currently serves as co-chair for the CCDR/Symptom management disease site working group and member of the thoracic and hematology disease site working groups at the University of Hawaii Cancer Center. She has served as site PI for several CCDR/Symptom management clinical trials as well as serving as a non-physician investigator on cooperative group and industry therapeutic clinical trials. She also maintains an active role precepting nurse practitioner students.
Ashley Springer has no relevant financial relationships to disclose.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 3 Component(s)
Learn about fertility preservation in radiation oncology, including impacts, strategies, counseling, collaboration, and evidence-based guidelines.
Tune to the APSHO Radiation Oncology APP Network for a webinar on Fertility Preservation in Radiation Oncology: Counseling and Options with Emery Bergey, MBA, MSN, APRN, AGCNS-BC, OCN.
- Understand the impact of radiation on fertility
- Identify fertility preservation strategies
- Enhance counseling and shared decision-making skills
- Navigate multidisciplinary collaboration and referral pathways
- Apply evidence-based guidelines and institutional protocols
The content of this webinar is presented by APSHO but does not necessarily reflect the views, opinions, or ideas of APSHO as an organization. The content has not been peer-reviewed and is not eligible for continuing education credits. APSHO is not responsible for any medical decisions made by attendees based on the information provided in this presentation. Any issues, concerns, or questions regarding the presentation should be directed to info@apsho.org.
Emery Bergey (Moderator)
MBA, MSN, APRN, AGCNS-BC, OCN
Moffitt Cancer Center
Emery Bergey, MBA, MSN, APRN, AGCNS-BC, OCN, is a clinical nurse specialist and advanced practice provider in the department of Radiation Oncology at Moffitt Cancer Center in Tampa, Florida. She holds multiple advanced degrees and certifications, including a Master of Science in Nursing Education, an MBA, and a post-master’s certificate in advanced practice nursing. Emery has extensive experience in oncology nursing, Lean Six Sigma, and trauma-informed care. She has worked as a lead RN case manager at the University of Florida Proton Therapy Institute and is a National Innovation and Entrepreneurship Fellow. Emery is dedicated to advancing holistic care for adolescent and young adult oncology patients and advocating for oncofertility care.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 21 Product(s)
The Advanced Practitioner Radiation Oncology (APRO) course is a specialized, in-depth program designed for advanced practitioners seeking to enhance their knowledge and clinical expertise in radiation oncology. This course provides a comprehensive understanding of radiation biology, treatment planning, disease-specific management, and patient-centered care, equipping participants with the skills to improve patient outcomes in a multidisciplinary setting.
The following topics will be covered in this course:
- Introduction to Radiation Oncology
- Radiation Biology and Physics
- Radiation Safety and Compliance
- Radiation Treatment Delivery
- Patient Evaluation and Simulation
- Disease Overview: CNS Tumors
- Disease Overview: Head and Neck Tumors
- Disease Overview: Chest (Breast/Lung) Tumors
- Disease Overview: GI Tumors
- Disease Overview: GU Tumors
- Disease Overview: GYN Tumors
- Disease Overview: Systemic, Palliative, Emergent and Benign Conditions
- Common Toxicities: Acute
- Common Toxicities: Late/Long Term
- Emerging Changes
- Pediatric Considerations
- Supportive Care, Survivorship and Patient Education
- AP Practice Fundamentals for Radiation Oncology
© APSHO 2025. All Rights Reserved. The content, materials, and intellectual property presented on this course, including but not limited to text, graphics, images, designs, logos, videos, and code, are the exclusive property of APSHO, unless otherwise noted. Unauthorized reproduction, distribution, or use of any content without prior written permission is strictly prohibited. For inquiries about licensing or permissions, please contact APSHO directly at info@apsho.org.
-
Register
- Non-member - $425
- Member - $375
- More Information
-
Contains 2 Component(s)
This module assists the learner to develop a manuscript for submission. The learner will learn to identify topics and develop manuscripts with useful tips provided by the faculty.
Manuscript Writing 101 covers essential steps from choosing a research topic to journal submission and peer review responses. This course was designed to help Advanced Practitioners master scientific writing, providing the tools and insights needed for successful publication. It is ideal for both beginners and those looking to refine their skills.
At the conclusion of this activity, participants will be able to:
- Discuss choosing the right research topic and journal
- Understand the manuscript submission process
- Navigating peer reviews and revisions
- Avoiding predatory journals
- Amanda Brink, DNP, APRN, FNP-BC, AOCNP
- Sandra Cuellar, PharmD, BCOP
- Cara Fleming, AGPCNP-BC, AOCNP
- Carolyn Grande, CRNP, AOCNP, FAPO
- Amber Koehler, PA-C
- Heather Lewin, MSN, APRN
- Gayathri Moorthy, PhD, APRN, AOCNP
- Nancy Nix, PharmD, BCPS, BCOP
- Anshika Singh, PharmD
- Gabriele Urschel, DNP, RN, FNP-C, AOCNP
- Constance Visovsky, PHD, RN, ACNP, FAAN
- Amelia Wodzinski, RN, CRNP, AOCNP
- Wendy Vogel, MSN, FNP, AOCNP, FAPO
- Heather Koniarczyk, MSN, APRN-CNP, AOCNP, FAPO
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP
Clinical Associate Professor, Clinical Oncology Pharmacist
University of Illinois at Chicago (UIC), UI Health
Dr. Sandra Cuellar is a Clinical Associate Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago (UIC) College of Pharmacy and a clinical oncology pharmacist at UI Health. She received her PharmD degree from the University of Illinois at Chicago College of Pharmacy and then completed a Pharmacy Practice Residency at University of Kentucky Chandler Medical Center. Following her residency, she completed a specialty oncology residency at MD Anderson Cancer Center in Houston. Dr. Cuellar is the director of the oncology residency program and chair of the IRB at UI Health. Dr. Cuellar is an editor at large for the Journal of Hematology Oncology Pharmacy and an invited lecturer to national organizations, including HOPA, ASHP, ACCP, ACCC, and AMCP. In addition, Dr. Cuellar was recently appointed to be a member of the ASHP Commission on Credentialing and past chair of the industry relation council for the Hematology Oncology Pharmacy Association.
-
Register
- Member - Free!
- More Information
